TURNING NOVEL DISCOVERIES INTO
INNOVATIVE HEALTH CARE SOLUTIONS.
KANE BIOTECH INC. is a biotechnology company engaged in the development of products to prevent and disperse biofilms. Biofilms are a major cause of a number of serious medical problems including chronic infections and medical device related infections. They develop on surfaces such as catheters, prosthetic implants, teeth, lungs and the urogenital tract. Biofilms are pervasive, costly to deal with and approximately 80% of all human bacterial infections involve biofilms. The healing of chronic wounds alone costs the United States health care system $20 billion per year.
Symbol: KNE
Listing:TSX Venture Exchange
Auditors:
KPMG
2000 - One Lombard Place
Winnipeg, Manitoba
R3B OX3
Transfer Agent:
Canadian Stock Transfer Company Inc.
600, 333 - 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1